NCT07132385

Brief Summary

Throughout the menopause transition, women experience many symptoms (i.e., hot flashes, night sweats) that can significantly reduce their quality of life. Moreover, their risk of heart disease increases substantially. The years before menopause called "perimenopause" present a critical window of intervention to alleviate menopause symptoms and improve health outcomes. Our team is therefore interested in comparing the potential benefits of different approaches including following the Health Canada guidelines (i.e., accumulating 150 min of moderate-to-vigorous aerobic physical activity weekly); performing high-intensity interval training (HIIT), which involves alternating periods of intense exercise with periods of rest; or stretching in perimenopause. As a first step towards this goal, this study will assess how easy and enjoyable the interventions are to follow over a 6-week period. The information gained from this study will be used to perform a larger study with enough participants to assess the health and quality of life impacts of adopting these different strategies in perimenopause.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2025Jun 2026

First Submitted

Initial submission to the registry

August 12, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 20, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

August 12, 2025

Last Update Submit

September 2, 2025

Conditions

Keywords

menopauseperimenopauseexercise

Outcome Measures

Primary Outcomes (5)

  • Intervention Adherence

    Determined by the percentage of in-person and online sessions attended over those prescribed as well as exercise intensity adherence based on heart rate data collected via Garmin smartwatch

    End of week 6

  • Enrolment

    Determined by the percentage of participants enrolled in study over those assessed for eligibility

    End of week 6

  • Study Assessment Adherence

    Determined by the percentage of study assessments completed over those included as part of the study.

    End of week 6

  • Attrition

    Determined by the percentage of participants who request withdrawal, are lost to follow-up, or experience injury preventing completion of the study over those enrolled

    End of week 6

  • Intervention acceptability

    Assessed via an intervention-specific researcher-developed questionnaire

    End of week 6

Secondary Outcomes (17)

  • Systemic insulin resistance

    6 weeks

  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)

    Calculated as: (fasting insulin*fasting glucose)/22.5 6 weeks

  • Cardiorespiratory fitness

    6 weeks

  • Body circumferences

    6 weeks

  • Whole-body fat and fat free mass

    6 weeks

  • +12 more secondary outcomes

Study Arms (3)

Guidelines-based moderate-intensity continuous exercise

EXPERIMENTAL

150 weekly minutes of moderate-intensity aerobic activity

Behavioral: Guidelines-based moderate-intensity continuous exercise

High-intensity interval training

EXPERIMENTAL

Periods of high intensity effort (1-4 min) interspersed with periods of rest (1-3 min)

Behavioral: High-intensity interval training

Stretching exercise

ACTIVE COMPARATOR

whole-body stretching

Behavioral: Stretching exercise

Interventions

Through a combination of exercise trainer-led in-person and virtual sessions, participants will be guided to achieve 150 weekly minutes of moderate-intensity aerobic activity (total intervention is 6 weeks)

Guidelines-based moderate-intensity continuous exercise

Through a combination of exercise trainer-led in-person and virtual sessions, participants will be guided to achieve 75 weekly minutes of high-intensity interval training.

High-intensity interval training

Twice weekly virtual instructor-led whole-body stretching class.

Stretching exercise

Eligibility Criteria

Age40 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Biological females in early and late perimenopause. Menopausal stage will be defined according to the Stages of Reproductive Aging Workshop +10 (STRAW+10). According to STRAW+10, perimenopause is characterized by menstrual cycle irregularity, specifically defined as having bleeding in the previous 12 months but at least a 7-day difference from usual menstrual cycle length
  • Experiencing menopause symptoms (e.g., hot flashes, night sweats, joint stiffness)
  • Aged 40 years or older
  • Multiple risk factors for cardiometabolic disease, namely being sedentary (\<30 min of moderate-vigorous physical activity/week), having a BMI ≥25 kg/m2, and a waist circumference indicative of abdominal obesity, specific to BMI (e.g., BMI 25-29.9: WC: 90cm; BMI 30-34.9: WC: 105cm; BMI 35-35.9: WC:115cm).

You may not qualify if:

  • History of reproductive surgeries including oophorectomy, hysterectomy, ablation or gender-affirming.
  • Diagnosis of cardiovascular disease, type 2 diabetes, non-alcoholic fatty liver disease, cancer (except for non-melanoma skin cancer), respiratory disease (e.g., Chronic Obstructive Pulmonary Disease or severe or uncontrolled asthma), uncontrolled hyper- or hypogonadism (change in medication or dosage in last 6 months and with major symptoms), and/or Polycystic Ovary Syndrome
  • Major signs or symptoms (regardless of known diagnosis) of cardiovascular diseases, diabetes, or renal disease
  • The use of medication that could impact blood glucose
  • Pregnant or post-partum \<12 months, lactating or breast feeding within 3 months of the start of study
  • Recreational smoking (e.g., tobacco, smoking)
  • Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins)
  • Using transdermal hormones, taking exogenous hormones, or receiving exogenous hormones from other means (e.g., intrauterine device)
  • Significant weight loss (i.e., \>5 kg) in past 3 months or currently taking weight loss medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goldring Centre for High Performance Sport

Toronto, Ontario, M5S 2C9, Canada

RECRUITING

MeSH Terms

Conditions

Motor Activity

Interventions

High-Intensity Interval TrainingMuscle Stretching Exercises

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Jenna Gillen, PhD

CONTACT

Clara Rivaya Salvadores, BKin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
It is not possible to blind participants to their assigned intervention. Care providers are not involved. The outcome assessors for any assessments involving potential for subjectivity in data collection or analysis will be blinded to group assignment.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 12, 2025

First Posted

August 20, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

September 9, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations